Author： Bose Salil
Publisher： Maney Publishing
ISSN： 2047-4814
Source： Medical Writing, Vol.22, Iss.2, 2013-06, pp. : 94-95
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Pharmaceutical regulatory medical writing for document submissions to Western health regulatory agencies has been undertaken in India for almost 10 years. From humble beginnings in a couple of non-Indian pharmaceutical multinational giants ‐ Novartis and Sanofi-Aventis (as it was) ‐ this activity has now expanded into multiple companies and almost a dozen information technology firms and contract research organisations. The biggest advantage is the cost, although this often comes at a ‘price’, in terms of document quality. However, medical writing in India may be turning a corner for the good as a result of the rapidly increasing body of experience in the field.
Related content
The changing face of medical writing in India
By Das Natasha
Medical Writing, Vol. 22, Iss. 2, 2013-06 ,pp. :
Access to resources
Recommend
Regulatory medical writing in Switzerland
Medical Writing, Vol. 22, Iss. 2, 2013-06 ,pp. :
Medical writing in the Middle East
Medical Writing, Vol. 22, Iss. 2, 2013-06 ,pp. :
By L鰊nfors Sanna Gilliver Stephen
Medical Writing, Vol. 22, Iss. 2, 2013-06 ,pp. :